Fusions comprising cancer cell-mediated peptides, multi-epitopes and TLR peptide agonists for cancer therapy

摘要

The present invention provides a complex for use in cancer prevention and / or treatment comprising a) a cell permeable peptide, b) at least one antigen or antigenic epitope, and c) at least one TLR peptide agonist, wherein component a ) To c) are covalently bonded. In particular, compositions are provided for use in the prevention and / or treatment of cancer, such as pharmaceutical compositions and vaccines.